Mezzasalma Advisors, LLC Bio N Tech Se Transaction History

Mezzasalma Advisors, LLC

  • $233 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022
SELL
$126.25 - $231.85 $592,112 - $1.09 Million
-4,690 Closed
0 $0
Q4 2021

Jan 31, 2022
BUY
$216.64 - $362.52 $23,830 - $39,877
110 Added 2.4%
4,690 $1.21 Million
Q3 2021

Oct 19, 2021
BUY
$205.93 - $447.23 $943,159 - $2.05 Million
4,580 New
4,580 $1.25 Million

Others Institutions Holding BNTX

# of Institutions
328
Shares Held
40.6M
Call Options Held
845K
Put Options Held
1.23M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $29.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Mezzasalma Advisors, LLC Portfolio

Follow Mezzasalma Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mezzasalma Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mezzasalma Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email